Building on these findings, we aimed to investigate the role of EZH2 inhibition as an immune-modulating strategy in LS colorectal mucosa using a murine model of LS colorectal carcinogenesis (herein referred to as VCMsh2THu) (25). The gene discussed is EZH2; the disease is Leigh syndrome.